Hey there, friend. It's your friend, Joe. Did you know that if your doctor prescribes you at Okoway's, there's less than a 1% chance that you'll become addicted? Sounds pretty harmless, right? Did you know that that statistic is entirely falls and misleading, but was heavily marketed to doctors and to our entire nation? For years, thanks to this guy, his billionaire clan, their money, and the sleaziest company in America? That statistic, in particular, was heavily marketed by Purdue Pharma and in a video called, From One Pain Patient to Another, was told to the audience. Side note that educational film was produced by Purdue Pharma. So let's dive into the sleazy story of this billionaire clan and their company, but first, let me talk about why this matters to me. Since the age of 18, I have been on pain management drugs and since I was 20, I've had access to pretty much unlimited opioids whenever I needed them. And as I was researching this video, I realized that I have literally been fed some of the lies that they told the public, that they probably told the doctors that I had seen, that I'm hoping the doctors believed innocently and didn't actually know the truth behind. God, that is the smell of some terrible, terrible people in the quotes that they have said. But before we get into that, let me give you a little bit of backstory. I'm honestly not sure how the dialogue around the rest of the world goes, but I live in America. And if you live in America, I can pretty much guarantee that if you've ever turned on the news, you have heard about the opioid crisis, the opioid epidemic, about drug users, drug abusers, drug deaths. Side note, if you are confused at all on what specifically opioids are, I'm going to put a link in the description that will give you a much clearer explanation of what that is than I can. But I'm going to assume that people generally have an idea of what it is and we're going to continue with this video. Humanity has known for a very long time about the addictive properties of opioids. Specifically, here in America after the Civil War, a lot of soldiers were giving morphine, which is an opioid for war wounds. It was administered pretty liberally and we pretty quickly had a problem with a lot, a lot, a lot, as in hundreds of thousands of soldiers becoming addicted. For a long time throughout history, doctors generally agreed that heavy prescription painkillers should only be prescribed to terminal patients, to people who were unfortunately going to die, they just needed their pain eased, or to people who were heavily supervised in a hospital environment. And that's it. Let's flash forward to the early 1990s when I was born, by the way. And it reduced you to Purdue Pharma and how they really changed the way that the medical community looked at pain. They did a very effective job at changing the narrative, the story about pain. A lot of doctors were already thinking maybe we don't actually take pain seriously enough. Let's paraphrase out of one of my favorite books, American Pain. By the early 1990s, some doctors were reconsidering their approach to pain. A small family-owned pharmaceutical company called Purdue Pharma was looking for ways to grow its customer base. Keep that in mind, looking for ways to grow its customer base. Purdue was best known for an extended release morphine drug called MS-cotton. Now, this was mostly used to treat terminal cancer patients, but their patent was about to expire. The company has a patent of something they make bank. That patent expires and generics are available. The amount of bank that they make goes down significantly. So they were working on developing a new drug called oxycontin, made out of oxycodone. Purdue didn't simply want to provide an alternative to MS-cotton. Purdue won an oxycontin to be prescribed to a much broader array of patients for a longer period of time. The untapped marketplace was chronic pain, which could mean anything from back eggs, arthritis, to the crippling agony of trigeminal neuralgia. If Purdue could persuade a portion of that vast and varied market to take oxycontin, the drug would be a blockbuster. We're just going to call this my sarcasm and anger hat. Also, it's not actually a hat. It's a cleaning box holder, but I like the hat option a little bit better. Here's the thing about Purdue, and yes, we will get back to the worst family in America, but the setup is pretty important. They were genius at marketing. One of the things that they did is they found opinion leaders. Essentially, they knew that doctors responded to the opinions of doctors more than sales reps. For instance, Dr. David Haddox, they hired and made a top executive. David Haddox essentially made up a term called pseudo-addiction. Pseudo-addicts were pain patients who exhibited drug-seeking behaviors, things like hoarding drugs, refilling drugs too early, reporting prescriptions of stolen more than once, taking higher and higher doses and higher doses than prescribed. He said these people looked like they were addicted, but they weren't addicted. They just needed more medication. This idea was based on a single case study of a single patient that doesn't even constitute a real study. This was basically just like an idea that he had. But Purdue Pharma and their board, who was made up of a number of the Sackler family members who were very involved and really liked the way that they sounded, and they gave them a lot of money to keep saying it. Back to how I started this video, Purdue actually funded a study. This study that was widely distributed cited an article from the New England Journal of Medicine. What it said is that the psychological addiction or dependence to narcotics is low for chronic pain patients. The citation for this wasn't an actual study. It was actually a letter to the editor of the New England Journal of Medicine. Written in 1980, the conclusions of this letter were not some big national study or anything like that. They were just based on some guy reviewing hospital charts and making a statement. But the idea was out there, published in a scientific journal. Fewer than 1% of pain patients would develop on addiction. This seriously makes me sick. Here's the other thing that they did really effectively. In the early 1990s, a bunch of articles started appearing. News stories, trend pieces, journal articles about how pain sufferers were suffering. They weren't getting prescribed the medicine. They needed doctors were essentially violating their Hippocratic oath to take care of people by withholding medicine. That was the line that was fed the public. That was absolutely in part funded by Purdue Pharma and the people running it. Purdue sales reps for OxyContin were paid very well. And they took doctors to very nice places to convince them about these things. For instance, the budget for steak dinners, food in general, alone for doctors was $9 million a year. They had $9 million a year set aside allocated for nice meals for doctors, for surgeons, for family practice doctors, for doctors in general, as they were convincing them and spreading lies about how these heavy opioids and narcotics needed to be prescribed to more and more and more and more people. Here's the thing that is so messed up about it. There are people who legitimately need heavy medication to exist, to make it through days who are in real chronic pain that does not have any better solution right now. So yes, absolutely. Chronic pain patients need good solutions. Part of that can sometimes include medications, opioids, but not for everybody. Not for people who have short-term back aches. Not for people who have toothaches. You shouldn't be giving people who have OxyToothaches. I'm not a doctor. I shouldn't make that statement. That's just my opinion. All of these articles had one basic message that millions and millions of Americans were suffering in needless pain. So you take that storyline and you combine that with, hey, less than 1% of people who are in chronic pain ever have any issue abusing the medication, ever mistake it, ever become dependent or addicted or anything like that. And you have a very effective marketing scene to get your drugs into the hands of millions. That is exactly what they did. Between 1996 and 2002, Purdue funded over 20,000 pain-related educational programs. I'll leave it up to your imagination what their bias was. Do you think it was to search for alternative therapies to get people active, to, you know, physical therapy, acupuncture, all different kinds of things, or do you think it was to get them to take drugs? It was to get them to take drugs. The educational seminars made the most of the unfounded statistic that fewer than 1% of patients would develop addictions.  When taken as prescribed, it's just fine. And here's the problem. When you have a patient that becomes addicted or overdoses and heart-breakingly dies, then they stuck to the narrative that, hey, when taken as prescribed, it's safe. Because those patients weren't taking it as prescribed. In one role-playing exercise, a patient comes in and admits to his doctor that he's been taking twice as much as you should be. He's essentially been abusing his medication. And the role-playing situation ends with his doctor prescribing twice as much medication, even more. Because that person shouldn't be flagged for help, for counseling, for, you know, anything else. No, just give them more drugs and let them keep taking more and more and more and more and more. Until what? They die? Again, I'm not against prescribing medication when it's necessary.  During some of these years, another one of their tools was to give away oxycontin coupons. They couldn't give away free samples of narcotic medications, according to the FDA. But you could give away coupons for a 30-day free supply of this drug and then it eventually became a 7-day free supply. But these are honestly dangerous medications that they were giving doctors coupons to just give to people. And it worked. It worked really well. By 2002, which was 6 years after the drug's release, they were bringing in $1.5 billion a year just from this medication alone. And then the death started happening. Enter one of the characters, Richard Sackler. He is the son of one of the founders of Purdue Pharmacy. He was the president of the company and a board member for a very long time. He had a very, very controlling micro-managing, according to some people, hand in the company. The news came out that recently 59 people had died in one state, all related to oxycontin. His response was, that's not too bad. Could have been worse. 59 people dead. That's not too bad. Could have been worse. We could have killed more people. Flashing forward a few years in 2017, the National Institute on Drug Abuse issued a statement that 47,000 people in 2017 died from drug-related overdoses, specifically to prescription opioids. That is 130 Americans a day, and this is just an America to re-clarify. They are working internationally. I just don't have those statistics. When more and more and more and more people died from his drug, Richard Sackler's response was, we have to hammer on the abusers in every way possible. They are the culprits. They are their problems. Reckless criminals is what he called people dealing with addiction to a drug that they knew was highly addictive, was highly dangerous, and that they had marketed and peddled to the masses with lies for years. Let's talk about the Sackler clan a little bit, shall we? They are billionaires. I would say good for them because I'm all for people making money, but the way they made this money is so appalling that I can't. I can't. Terrible for them. Bad for them. Shame on them. Their company has been sued and sued and sued, and most of the time they settled, nothing ever went through until 2007, when they actually admitted to lying and advertising that they had to pay $600 million in fines and three executives also additionally had to pay over $30 million each. This company was making billions, hundreds of thousands of people have died from it. I don't think that's just punishment, but who am I to say? If you know how companies and boards were, you know that sometimes board members can be, you know, pretty hands-off. They might not know what really is happening in the company, but Richard Sackler knew what was happening in the company. For instance, some people reported that he demanded to go out into the field of the sales reps. He would coach them on what to say, and in a quote that is very revealing, he said, You won't believe how committed I am to making OxyCotton a huge success. I've dedicated my life to it. In a court case deposition, he has asked if Purdue Farmers ever made any effort to find out how many patients were addicted to Oxy. His response was just a flat, nope, he did not say nope. He said no. I should clarify that. Now in 2019, decades after this all began, the Sacklers are finally being named in lawsuits against their company. Over half of the states in the United States are suing Purdue Pharma, and Connecticut has specifically named the Sackler family in one of the lawsuits. The allegation is that they misinformed patients and doctors to get more and more people on Purdue's dangerous drugs, which looking at the information is very accurate. Allow me just a moment to get a little emotional and drop the sarcasm here for just a second. As I began researching all of this, like the first article I read was on money.com. I was aware of a number of like the figures and the stats and like what the Sacklers did and Purdue Pharma and the general overarching story, but I really wanted to get into some details. And this was the first thing I came across. And it honestly, like immediately brought tears to my eyes. I was sitting at the kitchen table with my husband, 10 a.m. on a Saturday, and I just started crying. And this number is actually half of how high I've seen the estimates go, but according to the CDC, between 1999 and 2017, nearly 218,000 people have died from opioid related deaths. I knew it was a lot, but I didn't know it was quite that many. Think about that for just a second. And the people behind making these medications available like in mass knew what they were doing. They knew that they were lying. They did not do their due diligence at a bare minimum. But as I think is pretty clear, it went far beyond that. They didn't care. In one exchange between Richard Sackler and the creator of OxyContin, Richard was proposing the idea and trying to make it available like over-the-counter like aspirin. Like you could just go over to Walgreens and buy a bottle of Oxy. And the guy responded essentially saying that would have disastrous consequences. And Richard responding to him saying, yeah, but what would it do for a bottom line? For that full story, I will link it down below. Eight members of the Sackler family have sat on Purdue Pharma's board. Quick side note again, not every member of the Sackler family is like totally on board with lying to everybody and killing people through their drugs. There are a number of family members who have distanced themselves from the people involved with this. And I will also link that down below just so we don't condemn everybody.  But talking about the rest of the Sacklers, but talking about the rest of the Sacklers, they are well known for their philanthropy worldwide. For instance, their names are on Sackler Wings at the Metropolitan Museum of Art, the Louvre in Paris, Royal Academy in London. They have their name on rooms at the Guggenheim, the American Museum of Natural History. They have a Sackler staircase at the Jewish Museum in Berlin. Forbes.com estimates that the billionaire clan, like the bad Sackler people, that side of the family is worth a collective about $13 billion. Now, I'm curious how bad would someone have to be for you not to take $1.3 million from them? Well, that's what's happening right now with the National Portrait Gallery. The Sackler family and the National Portrait Gallery decided together, I'm going to put that in quotes, not to move forward with a project in which the Sacklers were donating $1.3 million to them. The Guggenheim has also stopped taking any donations from them. I believe this is happening with other organizations as well. If I can find those specific places, I'll put links again in the description. What this company and the people behind it have done is atrocious. At some point in the future, I'll do a video on what the opioid epidemic and crisis really is about. But I think what is really important to note and to come back to is what Richard Sackler said about blaming addicts. This does not happen worldwide, but we are really good here in America at shaming people who have addiction problems. Call them criminals, we take away their rights, we lock them up, we shame them, and we tell them that they're failures and they're horrible people. And that doesn't work. That does not work for helping people heal. That doesn't work for dealing with a very, very serious problem. But it is in the interest of Big Pharma to use a buzzword. It is in the interest of companies like Purdue Pharma. If all you do is shame and blame addicts and take no responsibility for miss marketing your drug for telling people it's not addictive, it's not a problem, it's going to be totally fine, it's just helping people. You know, Mr. Doctor, you'd really be breaking your Hippocratic Oath if you didn't help people with pain. Here, have some drug coupons. The things that they have said, the things that they have done are truly disgusting. You guys, I almost forgot a really important part of this whole story, which was one of the reasons I started making this video. Purdue Pharma recently announced as in in the last couple years that they were making a new drug to help wean addicts off of opioids. Now, on the surface, that's a good thing. Getting people off of drugs that are ruining their lives, that are hurting them is a good thing. Doesn't it turn your stomach just a little bit that the company that essentially manufactured this entire problem bare minimum was a huge part of it and lied to the entire American public about the risk of what they were taking is now standing to profit significantly off of fixing the problem that they made that is killing hundreds of thousands of people. If there is a drug out there that can help people get off of things safely, it should be out there. But the people who created the problem and lied to people about it should not be the people benefitting from it. Am I like the only person who feels that way? I'm not, and that's actually one of the reasons that all of this is kind of coming to the forefront because a lot of people just feel like that's wrong. They need to be held accountable and I sincerely hope that in the cases that are ongoing, they are held accountable. I hope that organizations continue to stop taking their money or give it back. I hope that their name is taken off more and more museum walls and room walls because they don't deserve to be there. If we allow this billionaire Klan's line and Purdue Pharma's line of blame the addict, it's their fault if they take it incorrectly even though it's not a dangerous drug to perpetuate and we continue to just jail addicts and treat them like crap, nothing is ever going to get better. And I'll also link a book in the description that deals specifically with ways other countries have dealt with addiction and effectively started to actually heal the problem and compassionately help people and guess what? It's a lot more effective than shaming them, calling them reckless criminals, throwing them in prison or just cutting off all help. Is the opioid crisis a complex problem? Absolutely. Are there a lot of prongs and a lot of storylines and a lot of people involved? Absolutely. Are other people to blame? Absolutely. But these people in this company played an integral role of what we see happening here in America and they need to be held accountable. Because yes, absolutely, people are in real pain, real physical pain and these medications absolutely do help. But when you peddle the idea to doctors over expensive dinners and resorts in Florida that it's not addictive, that it's totally fine and that it should be prescribed in higher and higher doses, we have an issue. As I began taking pain medication, I remember very clearly being told by a number of different sources by friends and articles and doctors that if you take it the right way, you'll never become addicted. If you take it, if you're in actual physical pain, you'll never have a problem. I have honestly believed that for years and that's not true. You can take it when you're in physical pain and still use it in an abusive way. That is important for people to simply be aware of. Much more than 1% of chronic pain patients who are ever prescribed opioids do get addicted.  Another quick side note guys, if you are curious about my story with narcotics, prescription drugs, all of that, check out this story above or look in the description. Now, for those of you who stuck around to the end of this pretty serious video, I have a present for you. A giveaway. I am giving away two books. The first one is American Pain. American Pain, I referenced a lot of today but I referenced kind of like the statistics and the boring parts. This is actually a fascinating read. It's like a true crime, really well written account, kind of in story form about everything happened. I started listening to it on Audible about a year ago and that's how I really got interested in all of this. Secondly, I am giving away a copy of Chasing the Scream. Chasing the Scream is written by Johann Haare and it's a fantastic book. I am almost done with it. I haven't quite finished it but it talks about the drug war on an international scale and what some countries are doing that is really really helping people. Again, it's written in a very conversational story way. This isn't like dry reading. I promise I wouldn't recommend any books to you that were like gonna bore you out of your mind. It's like they've snuck in all these statistics and super educational content within a fascinating story that you just don't want to put down. So if you want to enter, all you have to do is comment below. I will be picking the winner on Friday and announcing it in Friday's video. And if you don't win or you don't want to wait until it arrives in the mail, check out either one of these books on Audible.com. Like I said, I actually listened to this book about a year ago on Audible.com. It was sitting in my audio library for a while and I was like, ah, that's gonna be boring and I eventually clicked to download and listen to it and I could not stop. Audible is the world's largest library of audiobooks and I love audiobooks for a lot of reasons. One, because I can listen to them while I'm doing other things. I can listen to them in the car. I can hear stories and learn things while my hands are free and I'm doing other things. And as someone who does deal with chronic pain, I love audiobooks because I don't have to have my eyes open to read them. They're very passive. I can get a great story while resting. If you use the link below, you get a 30-day free trial of Audible, which comes with a free book, which means you could read either one of these and tell me what you think about it. Or you could choose something totally different and light and happy and fluffy and tell me how you enjoy that as well. Like I said, if you click that link below, you'll get that 30-day free trial and a free book and it would definitely help me out too, so I appreciate it. Thank you guys so much for sticking with me through today's video, which was a pretty dark, pretty tough topic. I really appreciate it and I would love to hear your comments specifically on all of this. Have you had any experience with it? Have you heard of any of this stuff before? Is it your first time, you know, learning about it? Also, John Oliver, who is one of my favorite comedians and talk show hosts, did his episode on Last Week Tonight two days ago about all of this. Ironically, I'd been researching it for about a week and a half and I saw that his show popped up about it. I was like, ah, that's awesome. Good timing. Without, also, I referenced the description a couple of times, but like I said, there will be a lot of links down there and also if there's any updates, corrections, anything like that, I will be posting it down below, so make sure you check the description. Thank you guys so much. I really appreciate you. I love you. I'll be thinking about you and I will see you in the next video. Bye guys.


What's up everyone? It's your girl Kenzie here from Layton Sports Cards and I'm ripping a personal here for Steven W. We've got three of the 2021 Panini Revolution basketball hobby boxes. All right Steven, best of luck. Let's see what we can get you. Let me some revolution basketball. Beautiful looking cards. Except for trying to get the box open. Any revolution product, I feel like it's hard. Here we go. Yeah, Steve. Me too. Me too.  We've got Fractal of Dennis Schroeder and Liftoff Jama Rant. Was that the doorbell? There's no way that could be here that quick. I can't tell if that was it or not. Astro rookie train man and rookie Evan Mobley. See when we get y'all out of one of these three boxes. Let's see, let's see. Astro Russell Westbrook and Kawai Leonard Vortex. Groove Collin Sexton and rookie of Jeremiah Robinson Earl. Is that it? Yeah, I heard something. There we go. We got Rockets. Rookie auto Alvin Shungoon. Here's an auto for you out of the first box. So still possibly more to come. We've got Impact out of 149. Collin Sexton, Franz Wagner on the Rookie Revolution and Vortex, Dame Dalla. Got Groove, Bones Hylings, Annie Charles, Bassie Rookie. Couple packs left in the first box here. Got Astro of Siakam. I don't know if we have four cards in it. I think we did have a pack that had a couple extra. A couple extra. Last pack, box one. Shockwave of Donovan Mitchell on the Fractal and a Bones Hylen Rookie Base. It's all in the first box. We did get an auto. Take that. See we've got a Galactic. That's the case here, right? Let's pull one of those out. Wow. Groove of Dijonte Murk. Santiago of Donovan Rookie Base. Got Grizzlies. Rookie auto. Zair Williams. All right. There we go. Steven, two for two so far on the autos. We will take those. Zair Williams. And we've got Derek White on the Impact out of 149 and Zair Williams Rookie Revolution. A Groove Rookie, Iodosunmuk and a Mamashu Billy Rookie. Astro Tyrese Maxi and Vortex of Luka Dachich. Hope everyone's having a great Monday night. Again, if you'd like to hop in queue about 30 to 45 minutes right now, you can find everything we've got available at latensportscards.com under the Personal Boxes tab. Jason Tatum on the Fractal. Supernova and Cameron Thomas Rookie. More group breaks over here tomorrow night for 10 Box Tuesdays starting at 5 p.m. Eastern. And then breaks starting tomorrow morning with Magic Mat over on the LSE Baseball page. Groove, Terry Rosear, the third. Lift off. John Collins for the Hawks.  Big release on Wednesday. We've got Tier 1 Bundesliga Soccer and Luminance Football. Erin Wiggins, Rookie Astro. Trey Murphy, the third. Last pack, Box 2. Astro Miles Turner and a Shockwave of Deem Dalla. All right, Box 3. Good luck, Stephen. Box 3. I got a replay of Dallas and Seattle now. Don't lose anything else on. I think it looks like it was just the baseball thing. Poker. We've got Supernova, Cubic, 47 to 50, Kade Cunningham. Three great boxes for him. Behind that, Evan Mobley, Rookie Revolution. Is it replay two? Yeah. Got Jared Butler, Groove Rookie and Kai Jones, Rookie Base. Astro, Jalen Brunson and Vortex, Trey Young. Shockwave, Steph Curry and a Jalen Suggs, Rookie. Groove, Lou Dort and Vortex, Davion Mitchell. Astro, Rookie of Khalate, Cat, Zacus, Rookie and Franz Wagner, Rookie. Astro of Lonzo Ball and Shockwave of Christo Arte.  Can we get an auto out of the last pack? Go for 3 for 3. I don't think so. Did get that really nice Kade out of this box. So Tyler Hero on the groove and Rookie of Josh Christopher Rockets. Alrighty, Stephen. That will do it for your boxes. Congrats again on the two autos and very nice Cubic Kade Cunningham. We'll get these right out to you.


Over to our mam, it's the Basel Chapman as we do each and every Tuesday at 20 past the hour and don't forget, folks, Basel does an outstanding program here every trading day. 10 to 11 Eastern Standard Time also is a great newsletter, the opening call. Now the way you get the opening call, folks, come over to our website at TFNN, you're going to hit Newsletters, you're going to see the opening call right on your left hand side, you just hit that Subscribe button, you can get the opening call for one month for $149. You can get it for six months, for $695, which is a savings of $199 or 22%, and you can get it for one full year for $1195, which is a savings of $593 or 33%. Now folks, they all come with a 30-day money-back guarantee. When you get Basel's newsletter, he has approximately 10 to 12 great archives out there. That all comes with it, great education, you can learn how to ride that wave each and every day. Basel Chapman, what's going on? Well, it's not what's going on, it's what's going up. It's amazing, this is a terrific move, yeah. It is, it's pretty wild. I mean, this has been a great trade near. I mean, that's the bottom line, so. Well, you know, look at this chart here in the middle. This is the weekly chart of the doubt. I've got a technique that I call the Chapman wave, inside track propellant zone, and at the top, it's the repellant zone. And look how the doubt, although it's an expanding wedge, look how the doubt has come down to this level each time and then had a really good rally. So the last one went right to the upper limit, that was the high of, I think it was 34, 281. It's actually where we've been short the doubt via the DOG. And look at this, it comes all the way down from that inside track repellant zone, almost to the bi-zone in the weekly. So it comes down to 28660, on October the 13th. We were actually long going into that, and then 830, the news came out and it suddenly dipped down and we had it quickly scurrying very soon after that. And it was the next day we went back to long again. But that was a very quick reversal. But look how interesting this is. If you look at the low that was made late September at 28,715 and then the lower, lower 28,660, you'll see the technicals on the left side. This is a daily chart. We're improving. Now, I like to use the inverse as well. It's like a mirror image, not always exact, but pretty close. Okay, how's the DOG? Okay. Late September, it goes to 38.45, pulls back, makes a cup formation. And what does it do? It fails at that cup formation and the cup becomes an arch formation at 38.66, and that goes to E. But look, the technicals on the left side were much stronger than on the right side where the MACD deflected low and very soon after that it turned negative. So this is the inverse, the DOG is one to one short and the DIA is one to one long. So I'll go back to the down. I'll show you something that's actually quite interesting here, is that there's a technique that I use called the Chapman wheat inside wedge. This green line, I usually make a dash. I made it solid for now, so it's easy to see. We went right to that level today. If this particular pattern, and I have a rule of one, three, five, meaning on the upside, if anything you're following retraces just for one bar and then makes a new recovery high or low, that's what you want. That's fantastic momentum to the upside. Three is still very good. When it gets to six, you have to almost restart the buy or the sell signal. So in this case, we rested for a day. That was off to peak A. We got to peak B. Almost one day, it was actually two days that we rested because we just failed to make leg C. And in the last few days we've screamed up in this leg C and the Chapman wave, you get a buy signal that gets upgraded which says you should go to at least four higher peaks then you gotta reassess. So we're in a buy mode. All the technicals are very good. We added to our original long position on Friday morning on that dip. We bought a very aggressive three times long the Dow. So we've had about a 17% gain just a few days on that position. So far, everything is good, but I must say, look at the weekly chart, there's a lot of work to be done to be able to go on even more to go up to that resistance level which is in the 32,700, 800 area. So far, it's a really good turnaround and you've seen that with some of the other indexes. But what I was looking at, I also, I'd mentioned to you last week that we had gone along Bank of America in the 31 area. We do this every year for subscribers in the last seven years. And we try to get something that is close to what it looks like a very good low and then we ride it all the way up and start taking money off until it turns around and we're out and then we try to do it again. So this year we've got it, this is the second attempt. This one so far is very good. We've gone 31 to 35.51. So that's very nice and the 200-period moving average resistance is at 3,602. But I want you to show you something here, the VIX index and I showed you this last week that Chapman-Inside-Track repellent zone that we did not close above that green line, the upper green line of this little mini down channel. And isn't that interesting? With all the news that went on, we only went to 34,88. We didn't even take out the June high of 3,505 and here we are sharply down and you see the date, that's the weekly chart. You see the daily chart? You said we went from a cup to an arch. Doesn't this look familiar? This is the VIX index. I've been talking about this all week. Look at this, any resemblance? There's your dollar. Okay, yeah. So the dollar, if that starts to take out 110 support it's gonna mimic the same pattern and it'll start to go down a little lower. So, so far what we're looking at is within the context of all the different indexes and the sectors that I was looking at to see if we could have a really good rally. We've got the TBT, which was on the upside bonds having an island reversal here to peak G. Nice pullback. We've got the, I even included the UNG the other day saying, I wanna see that turn as well because that would say that maybe oil steadies and doesn't go much higher and now finally natural gas can start to have a rally. And so far it's a nice turn to the upside. So I'm looking at this very positively and we've started, now we've started to add we built a big cash position we started to add and we're also adding single digit stocks which I think have very nice percentage gains. And if they in the same, the sector that's moving well it's nice to pick up something that maybe doesn't have the capitalization but it does have the percentage potential gain. So tomorrow I'll show a little bit more of some of these techniques in my show in the Tiger Technicians Hour at 10. Nice. You know what's so intriguing Basil is that we haven't had the Dow leading, I can't even remember. I mean, they're talking about 15, 20 years. Well, no, the Dow has held very well at times. It hasn't necessarily always led but it has held well but my contention has been for some time now that the maker, it's not the Dow industrials anymore it's the Dow 30 because- No, I hear that every day in a show, which is cool. Yeah, exactly. I don't think that that's important because that shows you the mix yet. It's only leading because it has insurance, it has the financials. Yeah, it's a good mix. Yeah, it's just a great mix. I like it very much and that's why we've been training it and so far so good. Yeah, no doubt. You never can't tell. No doubt. And folks, it's very easy to get Basil's newsletter.   You have a great night, safe night. Hey, so what's the weather like up there right now? Actually, it's starting to get cooler. I'm gonna go play tennis in a half an hour. It's getting very cool. Nice, nice. The time for tennis is gonna be ending very soon. It's a beautiful night. Okay, man, well, you have a great one, safe one. We look for a show tomorrow, Basil. You too. Thank you. Stay right there, folks, to come right back.